1QFU image
Deposition Date 1999-04-14
Release Date 1999-04-16
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1QFU
Title:
INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.28
R-Value Work:
0.19
Space Group:
P 3 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:PROTEIN (HEMAGGLUTININ (HA1 CHAIN))
Gene (Uniprot):HA
Chain IDs:A
Chain Length:328
Number of Molecules:1
Biological Source:Influenza A virus (A/X-31(H3N2))
Polymer Type:polypeptide(L)
Molecule:PROTEIN (HEMAGGLUTININ (HA2 CHAIN))
Gene (Uniprot):HA
Chain IDs:B
Chain Length:175
Number of Molecules:1
Biological Source:Influenza A virus (A/X-31(H3N2))
Polymer Type:polypeptide(L)
Molecule:PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY (HEAVY CHAIN))
Chain IDs:D (auth: H)
Chain Length:223
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY (LIGHT CHAIN))
Chain IDs:C (auth: L)
Chain Length:217
Number of Molecules:1
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Nat.Struct.Biol. 6 530 534 (1999)
PMID: 10360354 DOI: 10.1038/9299

Abstact

The structure of a complex of influenza hemagglutinin (HA) with a neutralizing antibody shows that the antibody binds to HA at a distance from the virus receptor binding site. Comparison of the properties of this antibody and its Fab with those of an antibody that recognizes an epitope overlapping the receptor binding site leads to two main conclusions. First, inhibition of receptor binding is an important component of neutralization. Second, the efficiency of neutralization by the antibodies ranks in the same order as their avidities for HA, and their large size makes these antibodies highly efficient at neutralization, regardless of the location of their epitope in relation to the virus receptor binding site. These observations provide rationales for the range of antibody specificities that are detected in immune sera and for the distribution of sequence changes on the membrane-distal surface of influenza HAs that occur during 'antigenic drift.'

Legend

Protein

Chemical

Disease

Primary Citation of related structures